HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harpole, D. H. Articles by Seigler, H. F. Search for Related Content PubMed PubMed Citation Articles by Harpole, D. H., Jr Articles by Seigler, H. F.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 743-748, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Analysis of 945 cases of pulmonary metastatic melanoma

DH Harpole Jr, CM Johnson, WG Wolfe, SL George and HF Seigler
Department of Surgery, Duke University Medical Center, Durham, N.C.

From 1970 to 1990, 7564 patients with melanoma were seen at Duke University Cancer Center. Complete follow-up data were available in all patients. The estimated probability of a pulmonary metastasis developing 5, 10, or 20 years after initial diagnosis was 0.13, 0.19, and 0.30, respectively. Pulmonary metastases were documented in 945 patients (12%), these having 1-, 3-, and 5-year survival rates of 30%, 9%, and 4%, respectively. The methods of diagnosis were chest radiograph (n = 544), computed tomography (n = 157), transthoracic needle biopsy (n = 121), bronchoscopy (n = 14), thoracotomy (n = 112), and autopsy (n = 7). Evidence of advanced pulmonic spread included bilateral disease in 543 and more than two nodules in 595. Univariate predictors for early formation of pulmonary metastases (p less than 0.001) were male sex, black race, increased primary thickness (millimeters), higher Clark's level, nodular or acral lentiginous histology, location on trunk or head and neck, and regional lymph nodes positive for metastasis. Multivariate predictors of improved survival (p less than 0.001) in order of importance were complete resection of pulmonary disease, longer time for formation of metastases, treatment with chemotherapy, one or two pulmonary nodules, lymph nodes negative for metastasis lymph nodes (p less than 0.005), and histologic type (p less than 0.04). Additionally, survival in patients with one nodule and resection (n = 84) was better than in those with similar disease and no resection (n = 142 months, p less than 0.001). These data comprise the largest series to date and emphasize the importance of long-term follow- up, as well as supporting the selective use of resection for isolated pulmonary metastases, increasing the 5-year survival rate from 4% to 20%.

This article has been cited by other articles:

				H. B. Neuman, A. Patel, C. Hanlon, J. D. Wolchok, A. N. Houghton, and D. G. Coit Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival Ann. Surg. Oncol., October 1, 2007; 14(10): 2847 - 2853. [Abstract] [Full Text] [PDF]

				R. P. Petersen, S. I. Hanish, J. C. Haney, C. C. Miller III, W. R. Burfeind Jr, D. S. Tyler, H. F. Seigler, W. Wolfe, T. A. D'Amico, and D. H. Harpole Jr Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 104 - 110. [Abstract] [Full Text] [PDF]

				E. C. Hsueh, R. Essner, L. J. Foshag, D. W. Ollila, G. Gammon, S. J. O'Day, P. D. Boasberg, S. L. Stern, X. Ye, and D. L. Morton Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine J. Clin. Oncol., December 1, 2002; 20(23): 4549 - 4554. [Abstract] [Full Text] [PDF]

				P. J. Allen and D. G. Coit The Surgical Management of Metastatic Melanoma Ann. Surg. Oncol., October 1, 2002; 9(8): 762 - 770. [Abstract] [Full Text] [PDF]

				M. T. Jaklitsch, C. M. Mery, J. M. Lukanich, W. G. Richards, R. Bueno, S. J. Swanson, S. J. Mentzer, B. D. Davis, E. N. Allred, and D. J. Sugarbaker Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 657 - 667. [Abstract] [Full Text] [PDF]

				J. R Sonett Pulmonary metastases: biologic and historical justification for VATS Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S13 - S16. [Full Text] [PDF]

				J. B. Zwischenberger and S. K. Alpard Pulmonary metastasectomy Ann. Thorac. Surg., July 1, 1999; 68(1): 287 - 288. [Full Text] [PDF]

				J. H. Robert, V. Ambrogi, B. Mermillod, D. Dahabreh, and P. Goldstraw Factors Influencing Long-Term Survival After Lung Metastasectomy Ann. Thorac. Surg., March 1, 1997; 63(3): 777 - 784. [Abstract] [Full Text]

				L. Tafra, P. S. Dale, L. A. Wanek, K. P. Ramming, and D. L. Morton Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 119 - 129. [Abstract] [Full Text]

				D. E. Maziak and M. F. McKneally Video-Assisted Thoracic Surgery Ann. Thorac. Surg., March 1, 1995; 59(3): 780 - 781. [Full Text]